This is not the most recent version of the article. View current version (8 DEC 2010)

Intervention Protocol

Antioxidant micronutrients for lung disease in cystic fibrosis

  1. Larissa Shamseer2,
  2. Denise Adams1,
  3. Neil Brown3,
  4. Jeffrey A Johnson4,
  5. Sunita Vohra1,*

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 24 AUG 2008

DOI: 10.1002/14651858.CD007020

How to Cite

Shamseer L, Adams D, Brown N, Johnson JA, Vohra S. Antioxidant micronutrients for lung disease in cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD007020. DOI: 10.1002/14651858.CD007020.

Author Information

  1. 1

    University of Alberta, CARE Program, Department of Pediatrics, Edmonton, Alberta, Canada

  2. 2

    Ottawa Hospital Research Institute, Ottawa Methods Centre, Clinical Epidemiology Program, Ottawa, Ontario, Canada

  3. 3

    University of Alberta, Department of Medicine, Edmonton, Alberta, Canada

  4. 4

    University of Alberta, Institute of Health Economics, Edmonton, Alberta, Canada

*Sunita Vohra, CARE Program, Department of Pediatrics, University of Alberta, 8B19 11111 Jasper Avenue, Edmonton, Alberta, T5K 0L4, Canada. svohra@ualberta.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article.View current version (08 Dec 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To synthesize existing knowledge on the effect of antioxidant micronutrients (vitamin C, vitamin E, beta-carotene and selenium) on lung function through inflammatory and oxidative stress markers in people with CF.